Clinical trial
Randomised Trial of Anti-Cd20 in C4d+ Chronic Allograft Nephropathy
NCT00476164 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Trial of Anti-Cd20 in C4d+ Chronic Allograft Nephropathy
- Lead sponsor
- King's College London
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- April 30, 2017
- Enrollment
- 62 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
graft rejection, immunosuppression, kidney transplantation